116 related articles for article (PubMed ID: 34051227)
21. Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.
Greenshields A; Bray RA; Gebel HM; Liwski RS
Hum Immunol; 2019 Jul; 80(7):468-477. PubMed ID: 31040048
[TBL] [Abstract][Full Text] [Related]
22. Implication of transfected cell lines for the detection of alloantibodies against human neutrophil antigen-3.
Bayat B; Tjahjono Y; Werth S; Berghöfer H; Reil A; Kroll H; Sachs UJ; Santoso S
Transfusion; 2012 Mar; 52(3):613-21. PubMed ID: 21883263
[TBL] [Abstract][Full Text] [Related]
23. [HLA and transfusion: new approaches with Luminex™ technology].
Giannoli C; Nguyen TK; Dubois V
Transfus Clin Biol; 2011 Apr; 18(2):218-23. PubMed ID: 21397543
[TBL] [Abstract][Full Text] [Related]
24. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.
Nakazawa Y; Saito S; Hasegawa Y; Yanagisawa R; Sakashita K; Kamijo T; Miyazaki T; Sato S; Ikeda H; Ikebuchi K; Koike K
Transfusion; 2007 Feb; 47(2):326-34. PubMed ID: 17302780
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of leucocyte alloantibodies in blood donors from South China.
Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
[TBL] [Abstract][Full Text] [Related]
26. Discrimination of HLA null and low expression alleles by cytokine-induced secretion of recombinant soluble HLA.
Hinrichs J; Figueiredo C; Hirv K; Mytilineos J; Blasczyk R; Horn PA; Eiz-Vesper B
Mol Immunol; 2009 Apr; 46(7):1451-7. PubMed ID: 19195705
[TBL] [Abstract][Full Text] [Related]
27. Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity.
Gao B; Rong C; Porcheray F; Moore C; Girouard TC; Saidman SL; Wong W; Fu Y; Zorn E
Transplantation; 2016 Jan; 100(1):217-26. PubMed ID: 26285015
[TBL] [Abstract][Full Text] [Related]
28. [Comparative studies of serological typing and HLA-A, B antigen genotyping with PCR using sequence-specific primers].
Wu DL; Ling HX; Tang H
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1267-70. PubMed ID: 15567775
[TBL] [Abstract][Full Text] [Related]
29. The predictive value of epitope analysis in highly sensitized patients awaiting renal transplantation.
Laundy GJ; Bradley BA
Transplantation; 1995 Apr; 59(8):1207-13. PubMed ID: 7537397
[TBL] [Abstract][Full Text] [Related]
30. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
31. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
Jug R; Anani W; Callum J
Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
[TBL] [Abstract][Full Text] [Related]
32. A human monoclonal antibody that detects HLA-A1, A23 and A24 antigens.
Kubo K; Tachino J; Yamaguchi H; Kurachi T; Naoe T; Ohno R; Ueda K
Tissue Antigens; 1993 Apr; 41(4):186-9. PubMed ID: 8362410
[TBL] [Abstract][Full Text] [Related]
33. Donor-specific antibody detection: comparison of single antigen assay and Luminex crossmatches.
Caro-Oleas JL; González-Escribano MF; Toro-Llamas S; Acevedo MJ; Martinez-Bravo MJ; Aguilera I; Núñez-Roldán A
Tissue Antigens; 2010 Nov; 76(5):398-403. PubMed ID: 20630037
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a new microbeads assay for granulocyte antibody detection.
Schulz U; Reil A; Kiefel V; Bux J; Moog R
Transfusion; 2017 Jan; 57(1):70-81. PubMed ID: 27774621
[TBL] [Abstract][Full Text] [Related]
35. The Most Common HLA Alleles and Anti-HLA Antibodies to Know for Virtual Cross-Match.
Baştürk B; Kantaroğlu B; Kavuzlu M; Sarıtürk Ç
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):53-55. PubMed ID: 27805512
[TBL] [Abstract][Full Text] [Related]
36. H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells.
Maryanski JL; Accolla RS; Jordan B
J Immunol; 1986 Jun; 136(12):4340-7. PubMed ID: 3086429
[TBL] [Abstract][Full Text] [Related]
37. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies.
Regan J; Monteiro F; Speiser D; Kalil J; Pouletty P; Buelow R
Am J Kidney Dis; 1996 Jul; 28(1):92-8. PubMed ID: 8712228
[TBL] [Abstract][Full Text] [Related]
38. Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platform.
Ravindranath MH; Filippone EJ; Mahowald G; Callender C; Babu A; Saidman S; Ferrone S
Immunol Res; 2018 Oct; 66(5):584-604. PubMed ID: 30324227
[TBL] [Abstract][Full Text] [Related]
39. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
Kurokohchi K; Arima K; Nishioka M
J Hepatol; 2001 Jun; 34(6):930-5. PubMed ID: 11451179
[TBL] [Abstract][Full Text] [Related]
40. It's about time: The development and validation of a rapid optimized single antigen bead (ROB) assay protocol for LABScreen.
Liwski RS; Greenshields AL; Murphey C; Bray RA; Gebel HM
Hum Immunol; 2017; 78(7-8):489-499. PubMed ID: 28501500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
